CN Patent
CN113365992B — 用于沃塞洛托的制备的方法和中间体
Assigned to Curia Spain SA · Expires 2024-05-28 · 2y expired
What this patent protects
本发明涉及一种用于制备沃塞洛托或其盐或溶剂化物的方法,其包括式(I)或(I’)的化合物或其盐或溶剂化物的用途。
USPTO Abstract
本发明涉及一种用于制备沃塞洛托或其盐或溶剂化物的方法,其包括式(I)或(I’)的化合物或其盐或溶剂化物的用途。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.